HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgMk paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report.

AbstractBACKGROUND:
The monoclonal gammopathies are a group of plasma-cell proliferative disorders characterized by the secretion of monoclonal immunoglobulin (M protein or paraprotein). Some rare cases have revealed the specific affinity of paraprotein as autoantibody. Here we report a patient with monoclonal gammopathy of undetermined significance (MGUS) accompanied by a remarkable increase of anticardiolipin antibody (aCL) and an extensively decreased coagulation factor activity, however, without any clinical signs of antiphospholipid syndrome (APS) and bleeding.
RESULTS:
Our further investigation indicated that IgMκ paraprotein of this patient possessed an antibody activity against phospholipids so as to bind to cardiolipin and interfere with coagulation assay in vitro.
CONCLUSIONS:
This case might be indicative that an abnormality of coagulation tests, disturbed by IgMκ paraprotein, does not predict a risk of bleeding in this patient.
AuthorsXin-Yao Wu, Yu-Feng Yin, Jia-Lin Teng, Li-Wei Zhang, Cheng-de Yang
JournalBMC immunology (BMC Immunol) Vol. 18 Issue 1 Pg. 32 (06 23 2017) ISSN: 1471-2172 [Electronic] England
PMID28645246 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Cardiolipins
  • Immunoglobulin M
  • Immunoglobulin kappa-Chains
Topics
  • Autoantibodies (metabolism)
  • Blood Coagulation
  • Blood Coagulation Tests (methods, standards)
  • Cardiolipins (metabolism)
  • Diagnostic Errors (prevention & control)
  • Humans
  • Immunoglobulin M (genetics, metabolism)
  • Immunoglobulin kappa-Chains (genetics, metabolism)
  • Male
  • Middle Aged
  • Paraproteinemias (blood, diagnosis)
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: